ArticleEuropean heart journal2019

Are healthcare systems now ready to adopt sacubitril/valsartan as the preferred approach to inhibiting the renin-angiotensin system in chronic heart failure? The culmination of a 20-year journey.

No numbers read from the abstract.

Not cited yet